UK Neural Implants Market

UK Neural Implants Market Size, Share & Trends Analysis Report by Product (Deep Brain Stimulation (DCS), Spinal Cord Stimulation (SCS), and Vagus Nerve Stimulation (VNS)), by Application (Chronic Pain, Epilepsy, Parkinson's Disease (PD), and Others (Depression and Other Movement Disorders)), and by End-user (Hospitals, Outpatient Surgery Centers, and Specialized Neurological Centers (SNCs)) Forecast Period (2021-2027)
    Update Available - Forecast 2024-2030   

Published: May 2021 | Report Code: OMR2023491 | Category : Medical Devices | Delivery Format: /

The UK neural implants market is estimated to grow at a significant CAGR of 7.8% during the forecast period. The UK was the third-largest market for neural implants share in the European neural implants market. The market is growing at a healthy rate due to the rising adoption of technologically advanced neural implants and increased awareness about advanced treatment options for neurological disorders. The market penetration of neural implants is also high in the UK. This is mainly attributed to the rising number of target patient pool in the country. For instance, in 2018, the prevalence of PD was around 145,519 in the UK’s population aged 20 years and above and the prevalence was found to increase further with age. For instance, the prevalence in the age group 60-64 years was reported around 9,272, compared to 28,791 in the age group 75-79 in 2018.

In addition, the National Health Service (NHS) reported that around 50,000 people are living with a spinal cord injury in the UK, and around 2,500 people are injured or diagnosed with a life-changing spinal cord injury. Also, condition like obesity poses a significant threat to the country’s overall population. According to the Health Survey for England 2017 data, approximately 28.7% of adults in England were obese, and a further 35.6% were overweight, making a total of 64.3% who were either overweight or obese. Treatment with neural implants holds significant potential for such neurological disorders, which will drive the neural implants market growth in the UK.

The UK neural implants market is segmented based on product, application, and end-user. Based on the product, the neural implants market is segmented deep brain stimulation (DCS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). Based on application, the market is classified into Chronic Pain, Epilepsy, Parkinson's Disease (PD), and others (depression and other movement disorders). Based on end-user, the market is segmented into hospitals, outpatient surgery centers, and specialized neurological centers (SNCs).

Moreover, the UK neural implants market is highly consolidated, with major vendors accounting for dominant shares. Key players in the UK neural implants market are expected to drive sales and margin growth in their business by expanding sales organization, securing additional contracts with commercial payors, maintaining technology leadership through R&D, and continuing to build clinical evidence to support the benefits of the products as well as services. Abbott, Aleva Neurotherapeutics Sa, Boston Scientific Corporation, LivaNova PLC, Medtronic, Renishaw plc are some of the major neural implants market players in the UK.

Research Methodology

The market study of the UK neural implants market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  1. UK Neural Implants Market Research and Analysis by Product 
  2. UK Neural Implants Market Research and Analysis by Application
  3. UK Neural Implants Market Research and Analysis by End-user

The Report Covers

  • Comprehensive research methodology of the UK neural implants market.
  • This report also includes a detailed and extensive market overview with the key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the UK neural implants market.
  • Insights about market determinants which are stimulating the UK neural implants market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Key Strategy Analysis

3.2. Key Company Analysis

3.2.1. Overview

3.2.2. Financial Analysis

3.2.3. SWOT Analysis

3.2.4. Recent Developments

4. Market Determinants 

4.1 Motivators

4.2 Restraints

4.1. Opportunities 

5. Market Segmentation

5.1. UK Neural Implants Industry Market by Product

5.1.1. Deep Brain Stimulation (DCS)

5.1.2. Spinal Cord Stimulation (SCS)

5.1.3. Vagus Nerve Stimulation (VNS)

5.2. UK Neural Implants Market by Application

5.2.1. Chronic Pain

5.2.2. Epilepsy

5.2.3. Parkinson's Disease (PD)

5.2.4. Others (Depression and Other Movement Disorders)

5.3. UK Neural Implants Market by End-user

5.3.1. Hospitals

5.3.2. Outpatient Surgery Centers

5.3.3. Specialized Neurological Centers (SNCs)

6. Company Profiles

6.1. Abbott

6.2. Aleva Neurotherapeutics SA

6.3. BIOS

6.4. Boston Scientific Corporation

6.5. LivaNova PLC

6.6. Medtronic

6.7. Renishaw plc

6.8. Saluda Medical Pty Ltd.

1. UK NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)

2. UK NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

3. UK NEURAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

1. UK NEURAL IMPLANTSMARKET SHARE BY PRODUCT, 2020 VS 2027 (%)

2. UK NEURAL IMPLANTSMARKET SHARE BY APPLICATION, 2020 VS 2027 (%)

3. UK NEURAL IMPLANTSMARKET SHARE BY END-USER, 2020 VS 2027 (%)